US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OnKure Therapeutics, Inc.

3.94

+0.01000.25%

Post-market: 3.940.00000.00%19:12 EDT

Volume:59.91K

Turnover:237.11K

Market Cap:159.16M

PE:-1.13

High:4.07

Open:3.95

Low:3.90

Close:3.93

52wk High:5.38

52wk Low:2.23

Shares:40.40M

Float Shares:33.68M

Volume Ratio:0.36

T/O Rate:0.18%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4954

EPS(LYR):-4.4035

ROE:-46.91%

ROA:-29.26%

PB:0.92

PE(LYR):-0.89

Loading ...

Overview Company News Filings

Onkure Therapeutics Inc. : Oppenheimer Cuts Target Price to $14 from $30

THOMSON REUTERS

OnKure Therapeutics Reprices 1.7 Million Underwater Stock Options to $4.14 Per Share

Wall Street Analysts Are Bullish on Top Healthcare Picks

Onkure Therapeutics - Registering Offer and Sale of Class a Common Stock up to $100 Mln Through Leerink Partners - SEC Filing

THOMSON REUTERS

OnKure Therapeutics Q2 FY26 Net Loss Narrows to $15.35 Million; Loss Per Share Improves to $0.31

We're Not Very Worried About OnKure Therapeutics' (NASDAQ:OKUR) Cash Burn Rate

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and CalciMedica (CALC)

OnKure Therapeutics shareholders approved amended, restated 2024 equity incentive plan at annual meeting

OnKure Therapeutics (OKUR) Receives a Rating Update from a Top Analyst

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), OnKure Therapeutics (OKUR) and Cogent Biosciences (COGT)

Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Onkure Therapeutics Reports First Quarter 2026 Financial Results

THOMSON REUTERS

Onkure Therapeutics Inc expected to post a loss of 74 cents a share - Earnings Preview

OnKure Therapeutics files to sell 36.14M shares of Class A common for holders

OnKure Therapeutics announces annual shareholder meeting notice

OnKure Therapeutics initial beneficial ownership filing names AI Biotechnology LLC as 10% owner

OnKure Therapeutics (OKUR) Gets a Buy from JonesTrading

OnKure Therapeutics files Form 3; director Liam Ratcliffe reports no beneficial ownership

Onkure Therapeutics Inc : Leerink Partners Cuts Target Price to $11 From $29

THOMSON REUTERS

OnKure Therapeutics prices private placement at about $150 million gross proceeds

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/OKUR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"OKUR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OKUR\",,,,,undefined,":{"symbol":"OKUR","market":"US","secType":"STK","nameCN":"OnKure Therapeutics, Inc.","latestPrice":3.94,"timestamp":1787342400000,"preClose":3.93,"halted":0,"volume":59910,"hourTrading":{"tag":"盘后","latestPrice":3.94,"preClose":3.94,"latestTime":"19:12 EDT","volume":828,"amount":3262.92,"timestamp":1787353947533,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0025445292620864595,"floatShares":33678799,"shares":40395500,"eps":-3.4954,"marketStatus":"Market Closed","change":0.01,"latestTime":"08-21 16:00:00 EDT","open":3.95,"high":4.0728,"low":3.9,"amount":237106.62177599999,"amplitude":0.043969,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.4954,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1617940800000,"exchange":"NASDAQ","adjPreClose":3.93,"preHourTrading":{"tag":"盘前","latestPrice":3.93,"preClose":3.93,"latestTime":"09:28 EDT","volume":431,"amount":1636.7898653,"timestamp":1787318881018,"change":0,"changeRate":0,"amplitude":0.07888},"postHourTrading":{"tag":"盘后","latestPrice":3.94,"preClose":3.94,"latestTime":"19:12 EDT","volume":828,"amount":3262.92,"timestamp":1787353947533,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.36385876096188446,"impliedVol":0.6175,"impliedVolPercentile":0.5217},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OKUR\",,,,,undefined,":{"symbol":"OKUR","floatShares":33678799,"roa":"-29.26%","roe":"-46.91%","lyrEps":-4.403475,"volumeRatio":0.36385876096188446,"shares":40395500,"dividePrice":0,"high":4.0728,"amplitude":0.043969,"preClose":3.93,"low":3.9,"week52Low":2.23,"pbRate":"0.92","week52High":5.38,"institutionHeld":0,"latestPrice":3.94,"eps":-3.4954,"divideRate":0,"volume":59910,"delay":0,"ttmEps":-3.4954,"open":3.95,"prevYearClose":2.9,"prevWeekClose":3.99,"prevMonthClose":3.82,"prevQuarterClose":4.56,"fiveDayClose":3.99,"twentyDayClose":4.12,"sixtyDayClose":4.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OKUR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"OKUR","fiscalQuarterEnding":"2026/06","expectedEps":-0.58,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2026-05-05","symbol":"OKUR","fiscalQuarterEnding":"2026/03","expectedEps":-0.81,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-1.11},{"market":"US","date":"2026-03-12","symbol":"OKUR","fiscalQuarterEnding":"2025/12","expectedEps":-1.15,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.99},{"market":"US","date":"2025-08-12","symbol":"OKUR","fiscalQuarterEnding":"2025/06","expectedEps":-1.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-1.14},{"market":"US","date":"2025-05-06","symbol":"OKUR","fiscalQuarterEnding":"2025/03","expectedEps":-1.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":-1.19}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OKUR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OKUR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":6,"updateTime":1778126400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OKUR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OKUR","date":"2026-08-21","current":-1.127196,"percent":0.225108,"low":-5.826698,"twenty":-2.81728,"median":-0.752486,"eighty":-0.579875,"high":-0.416488,"avg":-1.532596,"sd":1.30441,"marketCap":159150494},"quantilePoints":[{"date":"2024-10-18","current":-0.566743,"twenty":-0.590487,"median":-0.58695,"eighty":-0.578615,"marketCap":23873500},{"date":"2024-10-25","current":-5.440362,"twenty":-1.566804,"median":-0.588529,"eighty":-0.583857,"marketCap":229169826},{"date":"2024-10-31","current":-5.53853,"twenty":-5.51383,"median":-0.595209,"eighty":-0.585182,"marketCap":233305021},{"date":"2024-11-08","current":-5.443529,"twenty":-5.51383,"median":-5.168028,"eighty":-0.586445,"marketCap":229303220},{"date":"2024-11-15","current":-5.044864,"twenty":-5.465063,"median":-5.164656,"eighty":-0.588845,"marketCap":225434812},{"date":"2024-11-22","current":-4.773218,"twenty":-5.441629,"median":-5.044864,"eighty":-0.591244,"marketCap":213296014},{"date":"2024-11-29","current":-4.603066,"twenty":-5.421362,"median":-4.955311,"eighty":-0.594567,"marketCap":205692591},{"date":"2024-12-06","current":-4.23888,"twenty":-5.387795,"median":-4.77471,"eighty":-2.052213,"marketCap":189418599},{"date":"2024-12-13","current":-3.232892,"twenty":-5.327258,"median":-4.623962,"eighty":-3.414388,"marketCap":144465030},{"date":"2024-12-20","current":-2.403027,"twenty":-5.244271,"median":-4.603066,"eighty":-2.584523,"marketCap":107381670},{"date":"2024-12-27","current":-2.444819,"twenty":-5.224724,"median":-4.480676,"eighty":-2.411385,"marketCap":109249178},{"date":"2025-01-03","current":-2.543328,"twenty":-5.168028,"median":-4.415003,"eighty":-2.435864,"marketCap":113651159},{"date":"2025-01-10","current":-2.331384,"twenty":-5.162633,"median":-4.235895,"eighty":-2.394669,"marketCap":104180229},{"date":"2025-01-17","current":-1.794061,"twenty":-5.159079,"median":-4.098579,"eighty":-2.308697,"marketCap":80169421},{"date":"2025-01-24","current":-1.605998,"twenty":-5.09033,"median":-3.232892,"eighty":-1.908093,"marketCap":71765638},{"date":"2025-01-31","current":-1.740329,"twenty":-5.041282,"median":-2.694077,"eighty":-1.735553,"marketCap":77768340},{"date":"2025-02-07","current":-1.698537,"twenty":-4.988744,"median":-2.570194,"eighty":-1.722418,"marketCap":75900833},{"date":"2025-02-14","current":-1.680626,"twenty":-4.917698,"median":-2.540343,"eighty":-1.700328,"marketCap":75100472},{"date":"2025-02-21","current":-1.629879,"twenty":-4.846055,"median":-2.485118,"eighty":-1.698537,"marketCap":72832785},{"date":"2025-02-28","current":-1.459727,"twenty":-4.775009,"median":-2.435864,"eighty":-1.629879,"marketCap":65229362},{"date":"2025-03-07","current":-1.510474,"twenty":-4.72068,"median":-2.35825,"eighty":-1.588087,"marketCap":67497050},{"date":"2025-03-14","current":-1.170006,"twenty":-4.634708,"median":-2.331384,"eighty":-1.520623,"marketCap":61627741},{"date":"2025-03-21","current":-1.2754,"twenty":-4.622768,"median":-2.038842,"eighty":-1.494951,"marketCap":67179130},{"date":"2025-03-28","current":-1.196325,"twenty":-4.613812,"median":-1.835853,"eighty":-1.463309,"marketCap":63014023},{"date":"2025-04-04","current":-0.992261,"twenty":-4.603066,"median":-1.777643,"eighty":-1.2754,"marketCap":52265363},{"date":"2025-04-11","current":-0.755037,"twenty":-4.555304,"median":-1.746299,"eighty":-1.238668,"marketCap":39770044},{"date":"2025-04-17","current":-0.747384,"twenty":-4.482467,"median":-1.737344,"eighty":-1.209875,"marketCap":39366970},{"date":"2025-04-25","current":-0.675962,"twenty":-4.474705,"median":-1.713463,"eighty":-1.144127,"marketCap":35604938},{"date":"2025-05-02","current":-0.6377,"twenty":-4.44366,"median":-1.701522,"eighty":-1.004505,"marketCap":33589565},{"date":"2025-05-09","current":-0.454974,"twenty":-4.341569,"median":-1.694059,"eighty":-0.784115,"marketCap":26871652},{"date":"2025-05-16","current":-0.468834,"twenty":-4.237686,"median":-1.629879,"eighty":-0.752996,"marketCap":27690262},{"date":"2025-05-23","current":-0.489317,"twenty":-4.231716,"median":-1.626894,"eighty":-0.697899,"marketCap":28900031},{"date":"2025-05-30","current":-0.583311,"twenty":-4.22694,"median":-1.591073,"eighty":-0.663208,"marketCap":34451517},{"date":"2025-06-06","current":-0.654223,"twenty":-4.098579,"median":-1.549281,"eighty":-0.645352,"marketCap":38639741},{"date":"2025-06-13","current":-0.651936,"twenty":-3.686632,"median":-1.511967,"eighty":-0.647361,"marketCap":38504637},{"date":"2025-06-20","current":-0.553574,"twenty":-3.32364,"median":-1.503011,"eighty":-0.6377,"marketCap":32695165},{"date":"2025-06-27","current":-0.576449,"twenty":-3.001246,"median":-1.480623,"eighty":-0.606186,"marketCap":34046205},{"date":"2025-07-03","current":-0.544424,"twenty":-2.803631,"median":-1.468682,"eighty":-0.59365,"marketCap":32154749},{"date":"2025-07-11","current":-0.583311,"twenty":-2.690793,"median":-1.364985,"eighty":-0.585652,"marketCap":34451517},{"date":"2025-07-18","current":-0.544424,"twenty":-2.634673,"median":-1.2754,"eighty":-0.583311,"marketCap":32154749},{"date":"2025-07-25","current":-0.542136,"twenty":-2.584523,"median":-1.253011,"eighty":-0.577821,"marketCap":32019645},{"date":"2025-08-01","current":-0.505536,"twenty":-2.568403,"median":-1.219282,"eighty":-0.570959,"marketCap":29857981},{"date":"2025-08-08","current":-0.459786,"twenty":-2.55288,"median":-1.202702,"eighty":-0.560894,"marketCap":27155901},{"date":"2025-08-15","current":-0.598959,"twenty":-2.539746,"median":-1.170006,"eighty":-0.552659,"marketCap":36124995},{"date":"2025-08-22","current":-0.607932,"twenty":-2.515865,"median":-1.091743,"eighty":-0.553574,"marketCap":36666194},{"date":"2025-08-29","current":-0.630365,"twenty":-2.481834,"median":-0.992261,"eighty":-0.556319,"marketCap":38019190},{"date":"2025-09-05","current":-0.603445,"twenty":-2.459148,"median":-0.7984,"eighty":-0.559979,"marketCap":36395595},{"date":"2025-09-12","current":-0.547363,"twenty":-2.441237,"median":-0.779269,"eighty":-0.559219,"marketCap":33013104},{"date":"2025-09-19","current":-0.556336,"twenty":-2.422729,"median":-0.755037,"eighty":-0.552201,"marketCap":33554303},{"date":"2025-09-26","current":-0.569796,"twenty":-2.38631,"median":-0.742282,"eighty":-0.553574,"marketCap":34366100},{"date":"2025-10-03","current":-0.628121,"twenty":-2.358847,"median":-0.696368,"eighty":-0.554679,"marketCap":37883890},{"date":"2025-10-10","current":-0.70215,"twenty":-2.355265,"median":-0.682961,"eighty":-0.557061,"marketCap":42348777},{"date":"2025-10-17","current":-0.646068,"twenty":-2.345713,"median":-0.675962,"eighty":-0.559219,"marketCap":38966287},{"date":"2025-10-24","current":-0.668501,"twenty":-2.28601,"median":-0.669623,"eighty":-0.561583,"marketCap":40319283},{"date":"2025-10-31","current":-0.751502,"twenty":-2.19765,"median":-0.675962,"eighty":-0.562861,"marketCap":45325369},{"date":"2025-11-07","current":-0.70888,"twenty":-2.064514,"median":-0.682961,"eighty":-0.564537,"marketCap":42754676},{"date":"2025-11-14","current":-0.670407,"twenty":-1.908093,"median":-0.675901,"eighty":-0.567067,"marketCap":42541344},{"date":"2025-11-21","current":-0.559384,"twenty":-1.877048,"median":-0.672987,"eighty":-0.567067,"marketCap":35496281},{"date":"2025-11-28","current":-0.642651,"twenty":-1.828092,"median":-0.670575,"eighty":-0.566905,"marketCap":40780078},{"date":"2025-12-05","current":-0.561519,"twenty":-1.796449,"median":-0.668272,"eighty":-0.562792,"marketCap":35631763},{"date":"2025-12-12","current":-0.689622,"twenty":-1.787494,"median":-0.669454,"eighty":-0.563801,"marketCap":43760682},{"date":"2025-12-19","current":-0.664002,"twenty":-1.760628,"median":-0.668272,"eighty":-0.566905,"marketCap":42134898},{"date":"2025-12-26","current":-0.60849,"twenty":-1.75824,"median":-0.664002,"eighty":-0.567553,"marketCap":38612367},{"date":"2026-01-02","current":-0.619166,"twenty":-1.748687,"median":-0.663208,"eighty":-0.567553,"marketCap":39289777},{"date":"2026-01-09","current":-0.610625,"twenty":-1.741523,"median":-0.658197,"eighty":-0.568573,"marketCap":38747849},{"date":"2026-01-16","current":-0.642651,"twenty":-1.737941,"median":-0.661086,"eighty":-0.569434,"marketCap":40780078},{"date":"2026-01-23","current":-0.651191,"twenty":-1.73197,"median":-0.657597,"eighty":-0.569712,"marketCap":41322006},{"date":"2026-01-30","current":-0.58287,"twenty":-1.719433,"median":-0.655987,"eighty":-0.571043,"marketCap":36986583},{"date":"2026-02-06","current":-0.495333,"twenty":-1.713463,"median":-0.654223,"eighty":-0.567553,"marketCap":31431821},{"date":"2026-02-13","current":-0.514548,"twenty":-1.706298,"median":-0.651563,"eighty":-0.563419,"marketCap":32651159},{"date":"2026-02-20","current":-0.563654,"twenty":-1.701522,"median":-0.649432,"eighty":-0.562001,"marketCap":35767245},{"date":"2026-02-27","current":-0.567924,"twenty":-1.700328,"median":-0.647361,"eighty":-0.55996,"marketCap":36038209},{"date":"2026-03-06","current":-0.674677,"twenty":-1.698537,"median":-0.646714,"eighty":-0.561101,"marketCap":42812308},{"date":"2026-03-13","current":-0.751539,"twenty":-1.694955,"median":-0.648311,"eighty":-0.562001,"marketCap":47689660},{"date":"2026-03-20","current":-1.006271,"twenty":-1.686,"median":-0.651191,"eighty":-0.562861,"marketCap":59890214},{"date":"2026-03-27","current":-1.054517,"twenty":-1.660327,"median":-0.653327,"eighty":-0.563301,"marketCap":62761663},{"date":"2026-04-02","current":-0.935051,"twenty":-1.629879,"median":-0.654579,"eighty":-0.563654,"marketCap":55651409},{"date":"2026-04-10","current":-0.983297,"twenty":-1.629282,"median":-0.656897,"eighty":-0.563654,"marketCap":58522858},{"date":"2026-04-17","current":-1.072896,"twenty":-1.626894,"median":-0.658798,"eighty":-0.564272,"marketCap":63855548},{"date":"2026-04-24","current":-1.125737,"twenty":-1.622715,"median":-0.663208,"eighty":-0.566905,"marketCap":67000468},{"date":"2026-05-01","current":-3.576863,"twenty":-1.670477,"median":-0.666257,"eighty":-0.567553,"marketCap":212884179},{"date":"2026-05-08","current":-2.722874,"twenty":-1.700925,"median":-0.669454,"eighty":-0.567627,"marketCap":159966100},{"date":"2026-05-15","current":-2.296565,"twenty":-1.725403,"median":-0.670407,"eighty":-0.568105,"marketCap":134920903},{"date":"2026-05-22","current":-2.798509,"twenty":-1.755852,"median":-0.672987,"eighty":-0.56898,"marketCap":164409603},{"date":"2026-05-29","current":-2.832889,"twenty":-1.797046,"median":-0.674677,"eighty":-0.569586,"marketCap":166429377},{"date":"2026-06-05","current":-2.956656,"twenty":-2.117791,"median":-0.675962,"eighty":-0.569796,"marketCap":173700564},{"date":"2026-06-12","current":-2.922276,"twenty":-2.269061,"median":-0.681521,"eighty":-0.571874,"marketCap":171680790},{"date":"2026-06-18","current":-2.94978,"twenty":-2.332671,"median":-0.683589,"eighty":-0.571874,"marketCap":173296609},{"date":"2026-06-26","current":-2.901648,"twenty":-2.362053,"median":-0.685352,"eighty":-0.573704,"marketCap":170468925},{"date":"2026-07-02","current":-3.066671,"twenty":-2.439446,"median":-0.69542,"eighty":-0.574262,"marketCap":180163840},{"date":"2026-07-10","current":-3.066671,"twenty":-2.515865,"median":-0.703086,"eighty":-0.575601,"marketCap":180163840},{"date":"2026-07-17","current":-2.819137,"twenty":-2.584523,"median":-0.710973,"eighty":-0.576495,"marketCap":165621468},{"date":"2026-07-24","current":-2.901648,"twenty":-2.715447,"median":-0.728053,"eighty":-0.576526,"marketCap":170468925},{"date":"2026-07-31","current":-2.750377,"twenty":-2.739376,"median":-0.735368,"eighty":-0.577356,"marketCap":161581920},{"date":"2026-08-07","current":-2.862783,"twenty":-2.793008,"median":-0.744773,"eighty":-0.5786,"marketCap":168059682},{"date":"2026-08-14","current":-2.690326,"twenty":-2.799823,"median":-0.749443,"eighty":-0.578654,"marketCap":157935605},{"date":"2026-08-21","current":-2.711021,"twenty":-2.81728,"median":-0.752486,"eighty":-0.579875,"marketCap":159150494}],"updateTime":1787445959082},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OKUR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659141865","title":"Onkure Therapeutics Inc. : Oppenheimer Cuts Target Price to $14 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2659141865","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659141865?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:34","pubTimestamp":1786710854,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nAZN4TEAXH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","OKUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659158728","title":"OnKure Therapeutics Reprices 1.7 Million Underwater Stock Options to $4.14 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2659158728","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659158728?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:04","pubTimestamp":1786615452,"startTime":"0","endTime":"0","summary":"OnKure Therapeutics reprices 1.7 million underwater stock options to $4.14 per shareOnkure Therapeutics set an option repricing effective Aug. 7, 2026 for underwater employee and consultant stock opti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL9P3DtT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OKUR","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650653","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650653?lang=en_us&edition=fundamental","pubTime":"2026-08-06 11:00","pubTimestamp":1785985236,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on McKesson (MCK) and OnKure Therapeutics (OKUR) with b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-282?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-282?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0742534661.SGD","MCK","LU0965509101.SGD","LU2089984988.USD","LU0251131958.USD","LU1934455194.USD","LU0124676726.USD","LU1814569148.SGD","LU0203347892.USD","OKUR","LU0861579265.USD","BK4588","LU2112291526.USD","LU2468319806.SGD","LU1037948897.HKD","LU1430594728.SGD","LU0965508806.USD","LU1057294990.SGD","LU0432979614.USD","LU1366192091.USD","LU1506573853.SGD","LU1037948541.HKD","LU1983260115.SGD","LU1934455277.USD","LU0868494708.USD","LU0942090050.USD","LU0689626769.HKD","LU1023059063.AUD","LU0882574055.USD","LU1061106388.HKD","LU0314106906.USD","LU1585245621.USD","BK4585","BK4533","LU0114720955.EUR","BK4175","LU0251142724.SGD","LU0203345920.USD","LU0868494617.USD","LU0048573561.USD","LU0965509283.SGD","LU2324357040.USD","LU0965509010.AUD","BK4539","LU0122379950.USD","LU1934455863.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657562922","title":"Onkure Therapeutics - Registering Offer and Sale of Class a Common Stock up to $100 Mln Through Leerink Partners - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2657562922","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657562922?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:48","pubTimestamp":1785876506,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4411FS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","OKUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657564122","title":"OnKure Therapeutics Q2 FY26 Net Loss Narrows to $15.35 Million; Loss Per Share Improves to $0.31","url":"https://stock-news.laohu8.com/highlight/detail?id=2657564122","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657564122?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:30","pubTimestamp":1785875433,"startTime":"0","endTime":"0","summary":"OnKure Therapeutics Q2 FY26 net loss narrows to $15.35 million; loss per share improves to $0.31OnKure Therapeutics posted a Q2 net loss of $15.35 million, narrowing from $15.39 million a year earlier","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDLcgr8YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014005.SGD","BCDF","LU2210149790.SGD","NDAQ","BK4588","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","BK4585","BK4112","IE00BKPKM429.USD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4139","LU2095319765.USD","IE00B3QW5Z07.USD","BK4539","IE00BN0W2W23.USD","SG9999014039.USD","OKUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651108055","title":"We're Not Very Worried About OnKure Therapeutics' (NASDAQ:OKUR) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2651108055","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651108055?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:18","pubTimestamp":1784024327,"startTime":"0","endTime":"0","summary":"We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-okur/onkure-therapeutics/news/were-not-very-worried-about-onkure-therapeutics-nasdaqokur-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-okur/onkure-therapeutics/news/were-not-very-worried-about-onkure-therapeutics-nasdaqokur-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SQQQ","TQQY","ONEQ","JEPQ","NDX","QYLG","TECS","QQQE","BK4539","QID","QDTE",".IXIC","QLD","QQQ","QQQY","IYW","QQQJ","BK4139","FTEC","QQQA","TQQQ","NQmain","PSQ","GPIQ","QQQM","MNQmain","NVIW.SI","OKUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646817066","title":"Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646817066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646817066?lang=en_us&edition=fundamental","pubTime":"2026-06-25 01:40","pubTimestamp":1782322815,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on OnKure Therapeutics (OKUR) and CalciMedica (CALC). OnKure Therape...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-onkure-therapeutics-okur-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-onkure-therapeutics-okur-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0128526141.USD","BK4539","HCSG","BK4139","OKUR","XBI","BK4581","BK4137","BK4007","LABU","BK4588","XLV","CALC","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641624331","title":"OnKure Therapeutics shareholders approved amended, restated 2024 equity incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2641624331","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641624331?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:18","pubTimestamp":1780604291,"startTime":"0","endTime":"0","summary":"On June 3, 2026, Onkure Therapeutics held its annual shareholder meeting.Shareholders authorized an amended and restated 2024 equity incentive plan, including a one-time increase of 3,231,638 shares for issuance.The plan changes also removed the annual share cap from the evergreen provision while keeping the annual increase at 5% of outstanding shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onkure Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL3hWSSQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","OKUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634844396","title":"OnKure Therapeutics (OKUR) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2634844396","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634844396?lang=en_us&edition=fundamental","pubTime":"2026-05-10 09:57","pubTimestamp":1778378273,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Sam Slutsky from LifeSci Capital maintained a Buy rating on OnKure Therapeutics, with a price target of $16.00. Acc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/onkure-therapeutics-okur-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/onkure-therapeutics-okur-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OKUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633892135","title":"Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), OnKure Therapeutics (OKUR) and Cogent Biosciences (COGT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633892135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633892135?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:41","pubTimestamp":1778071266,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Novo Nordisk (NVO), OnKure Therapeutics (OKUR) and Cogent Bioscie...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-onkure-therapeutics-okur-and-cogent-biosciences-cogt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-onkure-therapeutics-okur-and-cogent-biosciences-cogt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","BK4007","IE00BZ1G4Q59.USD","NVOX","LU0128526141.USD","OKUR","COGT","BK4505","BK4599","NVOH","LU0029874061.USD","LU1093756325.SGD","BK4588","BK4585","XBI","NVO","IE00BKVL7J92.USD","BK4532","LABU","BK4539","LU0154236417.USD","BK4137","BK4139","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633978072","title":"Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633978072","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633978072?lang=en_us&edition=fundamental","pubTime":"2026-05-06 06:49","pubTimestamp":1778021366,"startTime":"0","endTime":"0","summary":"Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryOnkure Therapeutics Inc OKUR.OQ reported a quarterly adjusted loss of $1.11 per share for the quarter ended Mar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I3TL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKUR","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925095","title":"Onkure Therapeutics Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633925095?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:05","pubTimestamp":1778011505,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUA9GD1X8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","OKUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632124226","title":"Onkure Therapeutics Inc  expected to post a loss of 74 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2632124226","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632124226?lang=en_us&edition=fundamental","pubTime":"2026-05-01 21:01","pubTimestamp":1777640467,"startTime":"0","endTime":"0","summary":"Onkure Therapeutics Inc  expected to post a loss of74cents a share - Earnings Preview Onkure Therapeutics Inc OKUR.OQ OKUR.O is expected to  show a rise in quarterly revenue when it reports  results o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nL8N41E0Z2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKUR","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630273438","title":"OnKure Therapeutics files to sell 36.14M shares of Class A common for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2630273438","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630273438?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:12","pubTimestamp":1777061528,"startTime":"0","endTime":"0","summary":"16:05 EDT OnKure Therapeutics (OKUR) files to sell 36.14M shares of Class A common for holders Published first on TheFly – the ultimate source for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/onkure-therapeutics-files-to-sell-36-14m-shares-of-class-a-common-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/onkure-therapeutics-files-to-sell-36-14m-shares-of-class-a-common-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","LENZ","OKUR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629943050","title":"OnKure Therapeutics announces annual shareholder meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2629943050","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629943050?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:19","pubTimestamp":1776802742,"startTime":"0","endTime":"0","summary":"OnKure Therapeutics annual shareholder meeting set for June 3, 2026 in virtual format.Shareholders to vote on election of three Class II directors to serve through 2029.Vote also scheduled on amended and restated 2024 Equity Incentive Plan, including a one-time increase of 3,231,638 shares and removal of 2,407,100-share annual cap in evergreen provision.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onkure Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL17z15x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKUR","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625499897","title":"OnKure Therapeutics initial beneficial ownership filing names AI Biotechnology LLC as 10% owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2625499897","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625499897?lang=en_us&edition=fundamental","pubTime":"2026-04-08 09:15","pubTimestamp":1775610937,"startTime":"0","endTime":"0","summary":"OnKure Therapeutics disclosed Form 3 beneficial ownership filing dated 03/31/2026 for AI Biotechnology, flagged as a 10% owner.AI Biotechnology reported direct ownership of 3,998,332 shares of Class A common stock.Filing also reported pre-funded warrants covering 5,640,222 Class A shares with exercise price of USD 0.0001 per share.Access Industries Holdings, Access Industries Management, and Len Blavatnik were listed as additional reporting persons tied to the stake.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onkure Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on Apr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDLbXsJVx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKUR","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625860108","title":"OnKure Therapeutics (OKUR) Gets a Buy from JonesTrading","url":"https://stock-news.laohu8.com/highlight/detail?id=2625860108","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625860108?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:38","pubTimestamp":1775507888,"startTime":"0","endTime":"0","summary":"In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on OnKure Therapeutics, with a price target of $17.00. Roy covers ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/onkure-therapeutics-okur-gets-a-buy-from-jonestrading-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/onkure-therapeutics-okur-gets-a-buy-from-jonestrading-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","OKUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624544056","title":"OnKure Therapeutics files Form 3; director Liam Ratcliffe reports no beneficial ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2624544056","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624544056?lang=en_us&edition=fundamental","pubTime":"2026-04-02 05:24","pubTimestamp":1775078691,"startTime":"0","endTime":"0","summary":"OnKure Therapeutics director Liam Ratcliffe filed an initial Form 3 on March 31, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onkure Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL2wpdXJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKUR","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311010","title":"Onkure Therapeutics Inc : Leerink Partners Cuts Target Price to $11 From $29","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311010","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623311010?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:16","pubTimestamp":1774869397,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nFWN40I0FB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OKUR","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623316314","title":"OnKure Therapeutics prices private placement at about $150 million gross proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2623316314","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623316314?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:09","pubTimestamp":1774865364,"startTime":"0","endTime":"0","summary":"OnKure Therapeutics priced a private placement of Class A common stock, targeting gross proceeds of about $150 million.Deal includes 26.7 million shares priced at $4.15 per share.Investors also bought pre-funded warrants covering 9.4 million shares at $4.1499 per underlying share.Net proceeds earmarked for development of next-generation PI3Kα pan-mutant-selective inhibitor candidates, working capital.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onkure Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information containe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL98t6nk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OKUR","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}